论文部分内容阅读
/Massimino KP,Kolbeck KJ...//HPB 2012,14,14-19背景:门静脉栓塞(PVE)被用来促进健侧的肝脏增生,其安全性及有效性存在争议。本研究中,针对未来残肝体积(FLR)≦30%或伴有肝硬化的患者,在拟行肝脏切除术之前行包括或不包括IV段PV在内的右侧PV栓塞,以诱导左侧肝脏增生,我们试图分析关于右门静脉栓塞法(RPVE)和
/ Massimino KP, Kolbeck KJ ... // HPB 2012, 14, 14-19 Background: Portal venous thrombosis (PVE) is used to promote contralateral hepatic hyperplasia, the safety and efficacy of which is controversial. In this study, right PV embolus, with or without PV in segment IV, was included prior to hepatectomy for patients with future residual liver volume (FLR) ≦ 30% or cirrhosis to induce left flank Liver hyperplasia, we tried to analyze the right portal vein embolism (RPVE) and